Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 81 for “"Antibody engineering"”.

  1. Antibody engineering for improving breast cancer therapeutics.

    … is an IgG1 humanised anti-HER2 monoclonal antibody (mAb) which binds to the extracellular region of HER2. The therapeutic efficacy of trastuzumab has been attributed to direct mechanisms, including blockade of HER2 shedding from the tumour cell surface and inhibition of pro-tumoral …

    soton Download PDF for Antibody engineering for improving breast cancer therapeutics. (opens in a new tab)

  2. Phage display systems for antibody engineering and evaluation

    … of experimental and computational molecular engineering techniques. Functional screening of variant antibody libraries has proven essential for successful antibody development. Several protein display technologies have been deployed for this important screening phase, including phage display. …

    waikato-masters Repository record for Phage display systems for antibody engineering and evaluation (opens in a new tab) Download file for Phage display systems for antibody engineering and evaluation (opens in a new tab)

  3. Antibody engineering and antigen discovery against Avian Paramyxovirus

    <p>Twenty-five years since the first structure of Avian Orthoavulavirus (AOav) F protein was solved in the post-fusion conformation, the structure of the pre-fusion conformation remains elusive. AOaV is a major pathogen of poultry, especially chickens, and presents major challenges to small scale …

    oxford Repository record for Antibody engineering and antigen discovery against Avian Paramyxovirus (opens in a new tab)

  4. Using antibody next generation sequencing data to aid antibody engineering

    … of this thesis, we begin by describing a method (AntiBOdy Sequence Selector, “ABOSS”) for filtering BCR repertoire data, which considers the structural viability of each sequence and is orthogonal to all other current methods (Chapter 2). ABOSS leverages the presence/absence of a conserved …

    oxford Repository record for Using antibody next generation sequencing data to aid antibody engineering (opens in a new tab)

  5. USE OF ANTIBODY ENGINEERING TO IMPROVE THE PROPERTIES OF ANTIBODIES AS A REAGENTS

    Two different antibody engineering strategies were explored to obtain a best-in-class antibody for use against mouse p53 with particular focus on the immunohistochemical (?IHC?) staining of paraffin-embedded mouse tissue sections. The first approach utilised a novel selection platform ?SBP-display? …

    nus Repository record for USE OF ANTIBODY ENGINEERING TO IMPROVE THE PROPERTIES OF ANTIBODIES AS A REAGENTS (opens in a new tab) Download file for USE OF ANTIBODY ENGINEERING TO IMPROVE THE PROPERTIES OF ANTIBODIES AS A REAGENTS (opens in a new tab)

  6. Development of recombinant human monoclonal antibodies suitable for blood grouping using antibody engineering techniques

    … as well as or better than the human polyclonal antibody preparations which they have replaced. However, the detection of some blood groups is still reliant on the use of human polyclonal antisera, which is a less reliable reagent source with respect to availability, batch to batch variation and …

    unsw Repository record for Development of recombinant human monoclonal antibodies suitable for blood grouping using antibody engineering techniques (opens in a new tab)

  7. Proximity-induced Antibody Conjugation for Cancer and Bone Metastasis Treatment

    Antibody-based therapies entered the clinic over 30 years ago and have become a mainstream therapeutic option for patients with malignancies, infectious diseases, and transplant rejection. Compared with traditional chemotherapy, these biotherapeutics preferentially target cells presenting …

    rice Repository record for Proximity-induced Antibody Conjugation for Cancer and Bone Metastasis Treatment (opens in a new tab)

  8. Optimized Engineering Platform for the Generation of Recycling Therapeutic Antibodies

    A new modality in antibody engineering has emerged in which the antigen affinity is designed to be pH dependent (PHD). In particular, the combination of high affinity binding at neutral pH with low affinity binding at acidic pH leads to a novel antibody that can more effectively act on its target …

    buffalo Repository record for Optimized Engineering Platform for the Generation of Recycling Therapeutic Antibodies (opens in a new tab)

  9. Optimized protocol for antibody yeast display

    … bind strongly to targets of interest prior to antibody engineering, in vitro testing, and in vivo studies. For the purpose of efficiency and standardization, the goal of this work is to develop a protocol associated with yeast display for discovery of potent antibodies. In this work, the …

    texas Repository record for Optimized protocol for antibody yeast display (opens in a new tab)

  10. Development and characterisation of monoclonal antibodies to tumour endothelial marker ‘melanoma cell adhesion molecule’ (MCAM) and approaches to targeting MCAM on tumour vessels

    … rats, with two of them sub-cloned to stable antibody expressing hybridomas (mMCAM10 and mMCAM66). The two antibodies recognize mMCAM by flow cytometry, immunohistochemistry, Western blot and immunoprecipitation. The mMCAM10, but not the mMCAM66, localises to tumour vessels within one hour of …

    birmingham Download PDF for Development and characterisation of monoclonal antibodies to tumour endothelial marker ‘melanoma cell adhesion molecule’ (MCAM) and approaches to targeting MCAM on tumour vessels (opens in a new tab)

  11. Rapid, Site-Specific Labeling Of 'off-The-Shelf' And Native Serum Autoantibodies With T Cell-Redirecting Domains

    … antibodies typically requires extensive engineering and cloning. New technologies such as made-to-order genes, advanced expression systems, and high efficiency cloning have simplified and accelerated this process. However, the timeline to create new bispecific antibodies is in the order …

    penn Repository record for Rapid, Site-Specific Labeling Of 'off-The-Shelf' And Native Serum Autoantibodies With T Cell-Redirecting Domains (opens in a new tab)

  12. Exploiting the Heavy Chain Glycans for the Improvement of Radioimmunoconjugates

    … cover four main topics – (i) recent advances in antibody engineering for applications in immunoPET/SPECT, and RIT; (ii) evaluating the interplay of FcR with wild-type and aglycosylated variants of 89Zr-radiolabeled radioimmunoconjugates in various murine models of cancer; (iii) developing a …

    cuny-grad Repository record for Exploiting the Heavy Chain Glycans for the Improvement of Radioimmunoconjugates (opens in a new tab)

  13. Antibody detection of Burkholderia pseudommallei and Burkholderia mallei

    … found to be visually very similar. A monoclonal antibody raised to B. mallei LPS has been found to recognise both B. mallei and B. pseudomallei strains. However, in a small number of B. pseudomallei strains a visually atypical LPS profile has been demonstrated. A monoclonal ant ibody rai sed …

    aston Download PDF for Antibody detection of Burkholderia pseudommallei and Burkholderia mallei (opens in a new tab)

  14. Harnessing innovative methods in antibody design and delivery for development of a novel nonhormonal contraceptive

    … unintended pregnancies worldwide. As monoclonal antibody engineering continues to revolutionize drug development, a variety of strategies are being harnessed to establish antibody-based contraceptives. Human Contraception Antibody (HCA), an immunoglobulin G1 (IgG1) monoclonal antibody that …

    bu Repository record for Harnessing innovative methods in antibody design and delivery for development of a novel nonhormonal contraceptive (opens in a new tab)

  15. Antibody-Based Platform for Targeted Delivery to Antigen-Presenting Cells

    … novel subunit vaccine design with cutting-edge antibody engineering to specifically target Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (APCs) as a strategy to elicit robust immune responses against protein antigens. Built on an antibody scaffold, the ITV …

    toronto-retro Repository record for Antibody-Based Platform for Targeted Delivery to Antigen-Presenting Cells (opens in a new tab)

  16. Protein Multimodal Learning for Variant Effect Prediction and Protein Engineering

    … fitness prediction, we conducted computational antibody engineering without activity labels using our tailored antibody LM. Validated over a COVID-19 antibody benchmark set, we demonstrated the effectiveness of our pipeline to discover antibody variants with improved neutralization in a vast …

    tamu Repository record for Protein Multimodal Learning for Variant Effect Prediction and Protein Engineering (opens in a new tab)

  17. Engineering and Optimization of Adeno-Associated Virus-Vectored Immunoprophylaxis for Durable Protection Against Emerging Viral Pathogens

    … including optimization of therapeutic antibody design, durable transgene expression, host immune responses, and vector readministration. The overall objective of this thesis was to investigate complementary strategies to enhance the AAV-VIP platform through therapeutic antibody …

    guelph Repository record for Engineering and Optimization of Adeno-Associated Virus-Vectored Immunoprophylaxis for Durable Protection Against Emerging Viral Pathogens (opens in a new tab) Embargoed until 2027-08-31

  18. Targeting viral fusion for immunity and therapeutics against infection

    … enzyme 2 (ACE2). We found one non-neutralizing antibody, 54043-5, capable of binding multiple coronaviruses within the same genus. The structure of 54043-5 bound the SARS-CoV-2 spike fusion machinery revealed a highly conserved, cryptic epitope at the apex of the spike fusion machinery that may …

    texas Repository record for Targeting viral fusion for immunity and therapeutics against infection (opens in a new tab)

Page 1 of 5